Ghana vs South America: Proportion of the target population who received a 3rd dose of
Ghana
96.0%
in 2024
South America
77.0%
in 2024
Ghana rank
16th
South America rank
16th
Proportion of the target population who received a 3rd dose of over time
- Ghana
- South America
How they compare
Ghana currently reports 96.0% against 77.0% in South America, a difference of 19.0%.
That makes Ghana's figure about 1.2 times South America's.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was South America ahead.
Ghana ranks 16th and South America ranks 16th of 157 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | South America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.0% | 77.8% | 10.2% | Ghana |
| 2020s | 96.8% | 71.6% | 25.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Ghana or South America?
- Ghana, at 96.0% against 77.0% in South America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Ghana and South America?
- 19.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and South America?
- 13 years are reported by both, from 2012 to 2024.
- How do Ghana and South America rank globally for proportion of the target population who received a 3rd dose of?
- Ghana ranks 16th and South America ranks 16th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.